M. Lockett

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Melanie Lockett, M. Lockett, M Lockett, Melanie Jane Lockett, Melanie J. Lockett
Publication record
36 papers · 701 citations · H-index 12

PAPERS

A patient with CVID-enteropathy successfully treated with ustekinumab
20243 citationsauthor #2
Outcomes of complex colorectal polyps managed by multi-disciplinary team strategies—a multi-centre observational study
20237 citationsauthor #10
BSG cross-sectional survey on impact of COVID-19 recovery on workforce, workload and well-being
20224 citationsauthor #6
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
202276 citationsauthor #275
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
202228 citationsauthor #316
Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study
202218 citationsauthor #51
P378 A novel approach to managing patients with idiopathic gastroparesis
20210 citationsauthor #3
Training in therapeutic endoscopy: meeting present and future challenges
201917 citationsauthor #2
PWE-031 Re-evaluating investigation and management of anaemia in inflammatory bowel disease
20180 citationsauthor #6
Results of the British Society of Gastroenterology supporting women in gastroenterology mentoring scheme pilot
201817 citationsauthor #6
Gender differences in leadership, workforce and scholarly presentation within a national society: a gastroenterology perspective
201812 citationsauthor #6
Sheffield Clinical Research Fellowship programme: a transferable model for UK gastroenterology
20173 citationsauthor #10
Trends in UK endoscopy training in the BSG trainees’ national survey and strategic planning for the future
201736 citationsauthor #4
PTH-120 How Can We Improve Recruitment and Support Gastroenterology Trainees in The UK? Results from The Supporting Women in Gastroenterology (SWIG) Survey
20160 citationsauthor #7
OC-038 Making The Change: Switching to Infliximab Biosimilars for IBD at North Bristol NHS Trust
20166 citationsauthor #4
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.
2016104 citationsauthor #35
PWE-133 Female Representation in Leadership Roles: Results from The Supporting Women in Gastroenterology (SWIG) Survey
20160 citationsauthor #7
PTH-034 Hemospray may not reliably achieve hemostasis beyond 48 hours in acute upper gastrointestinal bleeding
20155 citationsauthor #4
PWE-064 Management Of Large Colonic Polyps In The Severn Deanery Hospitals: An Audit Of Current Practice
20140 citationsauthor #8
Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial.
201381 citationsauthor #4
Mo1422 Colorectal Cancer Surveillance in Inflammatory Bowel Disease: a Retrospective Audit of Primary and Secondary Care
20120 citationsauthor #4
P324 Colorectal cancer surveillance in inflammatory bowel disease: A retrospective audit of primary and secondary care
20122 citationsauthor #5
Colorectal cancer surveillance in inflammatory bowel disease: a primary care perspective
20110 citationsauthor #5
The medical management of inflammatory bowel disease in primary care: the north bristol experience
20112 citationsauthor #5
Training in gastroenterology in the south west: results of a survey of trainees and training leads
20110 citationsauthor #6
Updated BSG guidelines for cancer surveillance in IBD – improving consensus and changing practice?
20113 citationsauthor #3
VSL#3 for the prevention of antibiotic associated diarrhoea (AAD) and clostridium difficile associated diarrhoea (CDAD): an interim analysis
20115 citationsauthor #2
Out of programme experience and training: going away to bring something back
20105 citationsauthor #3
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease
201011 citationsauthor #4
T1122 Risedronate Protects Against Bone Loss When a Relapse of IBD Is Treated with Steroids
20080 citationsauthor #4
Molecular classification and genetic pathways in hyperplastic polyposis syndrome
200792 citationsauthor #3
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.
2003112 citationsauthor #3
Effect of real-time magnetic endoscope imaging on the teaching and acquisition of colonoscopy skills: results from a single trainee.
200342 citationsauthor #3
Hyperplastic polyposis (HPP): Prevalence and cancer risk
200114 citationsauthor #1
Examination of a low‐cost pocket Doppler device for fetal assessment
19980 citationsauthor #1
A comparison of systolic to diastolic ratios of the umbilical artery in high-risk pregnancies obtained using a duplex system and hand-held Doppler
19940 citationsauthor #1

TIMELINE

1994 0 citations

1998 0 citations

2001 14 citations

2003 154 citations

2007 92 citations

2008 0 citations

2010 16 citations

2011 10 citations

2012 2 citations

2013 81 citations

2014 0 citations

2015 5 citations

2016 110 citations

2017 39 citations

2018 29 citations

2019 17 citations

2021 0 citations

2022 126 citations

2023 7 citations

2024 3 citations

M. Lockett

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT